Aurigene to participate in AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA. Conference Link
BOSTON, August 5, 2015 /PRNewswire/- Aurigene will be presenting data at the poster session for its proprietary RAR-related orphan receptor gamma (RORγ) small molecule inverse agonists program, which is currently in preclinical
Aurigene to participate in International IRA Conference – World Congress on Inflammation (WCI) to be held at Boston, MA. Conference Link: https://inflammation2015.org/2015/Home.aspx
